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Edited by Laszlo NagyAbstract Agonist stimulation of G protein-coupled receptors
causes receptor activation, phosphorylation, b-arrestin binding
and receptor internalization. Angiotensin II (AngII) causes rapid
internalization of the AT1 receptors, whereas AngII-bound AT2
receptors do not internalize. Although the activation of the rat
AT1A receptor with AngII causes translocation of b-arrestin2
to the receptor, no association of this molecule with the AT2
receptor can be detected after AngII treatment with confocal
microscopy or bioluminescence resonance energy transfer. These
data demonstrate that the two subtypes of angiotensin receptors
have diﬀerent mechanisms of regulation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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AT1 and AT2 angiotensin receptors (AT1R and AT2R) are
members of the G-protein-coupled receptor (GPCR) super-
family, which bind the octapeptide hormone angiotensin II
(AngII). The signaling pathways of AT1R are well understood
[1]. Agonist stimulation causes the activation of heterotrimeric
G proteins leading to activation of protein kinase C (PKC) and
increase in cytoplasmic calcium concentration. Furthermore,
stimulation of the receptor leads to additional signaling mech-
anisms, such as activation of mitogen activated protein kinase
(MAP) kinases and the Janus kinase-signal transducers and
activators of transcription pathway (JAK/STAT) [2]. Receptor
activation also causes the desensitization and subsequent
sequestration of AT1R. Internalization of the AT1R occurs
with a b-arrestin and dynamin-dependent process at physio-
logical hormone concentrations, however, b-arrestin and dyn-Abbreviations: AngII, angiotensin II; AT1R, AT1 angiotensin receptor;
AT2R, AT2 angiotensin receptor; b-arr2GFP, EGFP tagged b-arres-
tin2; BRET, bioluminescence resonance energy transfer; EGFP, enh-
anced green ﬂuorescent protein; EYFP, enhanced yellow ﬂuorescent
protein; GPCR, G-protein-coupled receptor; GRK, GPCR kinase;
HEK, human embryonic kidney; JAK/STAT, Janus kinase signal
transducers and activators of transcription; MAP kinase, mitogen
activated protein kinase; PGE2, prostaglandin E2; PKC, protein kinase
C; Rluc, renilla luciferase
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doi:10.1016/j.febslet.2005.11.044amin-independent mechanisms of AT1R endocytosis have also
been reported [3,4]. Activated AT1R forms stable complexes
with b-arrestins, and internalized AT1R-associated b-arrestin
can be readily detected in endosomes [5].
Although the signaling and traﬃcking pathways of AT1Rs
are well characterized, much less is known about the signal
transduction pathways and regulation of AT2R. AT2R does
not modulate cytosolic Ca2+ or cAMP levels [6], but it can acti-
vate serine-threonine and tyrosine phosphatases [7,8], causes
apoptosis [9], and inhibit MAP kinase activation by other
receptors [10]. Studies in primary cells and expression systems
have demonstrated that, in contrast to AT1R, AngII-stimu-
lated AT2Rs do not internalize [11,12].
The agonist stimulation of the GPCRs is usually followed by
desensitization [13]. In case of heterologous desensitization
receptors are phosphorylated by second messenger dependent
serine-threonine kinases (protein kinase A and PKC), and phos-
phorylation also occurs on inactive receptors. This modiﬁcation
inhibits G protein coupling ofGPCRs. In contrast, homologous
desensitization is mediated by phosphorylation of activated
receptors by GPCR kinases (GRKs) and subsequent coupling
of b-arrestin1 or b-arrestin2. Binding of b-arrestins leads to
uncoupling of G protein and termination of the signal transduc-
tion. Although b-arrestin binding is a general property of acti-
vated GPCRs, the stability of the binding shows diﬀerences.
In case of some receptors, also called class A receptors (e.g.,
b2-adrenergic receptor), the binding is transient, and only oc-
curs at the cell membrane; whereas class B receptors, such as
AT1R, form stable complexes with b-arrestins, which can also
be detected in endosomes [5]. The two classes of receptors also
vary in binding aﬃnities to diﬀerent subtypes of b-arrestin.
Class A receptors bind b-arrestin2 with higher aﬃnity than b-
arrestin1, whereas class B receptors bind both isoforms equally
well [5]. b-Arrestins can also bind to components of the clathrin
coat (e.g., clathrin and b2-adaptin) causing subsequent internal-
ization of many GPCRs, including the AT1R. Recent studies
also revealed an important novel function of b-arrestins. In
addition to their role in the regulation of GPCRs, after associ-
ation with receptors, b-arrestin can also mediate G protein-
independent activation of MAP kinases [14]. Thus, b-arrestin
binding has highly signiﬁcant consequences on signal transduc-
tion and regulation of GPCRs.
Activated AT1R is phosphorylated by GRKs and PKC [15].
Phosphorylation of the AT2R by PKC has already been dem-
onstrated, but GRK-mediated phosphorylation of the AT2R
has not been detected [16]. Since GRK-mediated phosphoryla-blished by Elsevier B.V. All rights reserved.
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GPCRs, in the present study we have compared the abilities
of AT1R and AT2R to associate with b-arrestin2, which bounds
equally well to both classes of GPCRs, using confocal micros-
copy and bioluminescence resonance energy transfer (BRET).2. Materials and methods
2.1. Materials
The cDNA of the rat vascular smooth muscle AT1A receptor
(AT1R), provided by Dr. K.E. Bernstein (Emory University, Atlanta,
GA), was subcloned into pcDNA3.1 vector and inﬂuenza hemaggluti-
nin (HA) epitope was inserted as previously described [17,18]. The
AT2R was obtained from a rat brain cDNA library and subcloned into
pcDNAI/Amp vector [12]. b-arrestin2-EGFP was kindly provided by
Dr. Marc G. Caron (Duke University, Durham, NC). Rhodamine-
conjugated AngII (Rhod-AngII) was obtained from NEN Life Science
Products (Boston, MA). Coelenterazine h was from Molecular Probes
(Eugene, OR). 125I-AngII was kindly provided by Dr. R.C. Speth
(Univ. Mississippi, University, MS).
2.2. Plasmid constructs and transfection
b-Arrestin2-Rluc was generated by subcloning the b-arrestin2 into
the mammalian expression vector pEYFP-N1 (Clontech, Palo Alto,
CA) and replacing the enhanced yellow ﬂuorescent protein (EYFP)
with humanized renilla-luciferase (Promega, Madison, WI). AT1R-
EYFP and AT2R-EYFP were generated by ampliﬁcation of the recep-
tor and subsequently cloning into the mammalian expression vector
pEYFP-N1. For confocal microscopy, cells were grown on glass cov-
erslips and transfected with the indicated constructs using 3 ll/ml Fu-
GENE 6 (Roche Diagnostics, Nutley, NJ). Human embryonic kidney
(HEK) 293 cells were maintained in 5% CO2 in NaHCO3-buﬀered
DMEM medium containing 10% fetal bovine serum, 100 lg/ml strep-
tomycin, and 100 IU/ml penicillin (Invitrogen, Carlsbad, CA). For
BRET analysis, cells were grown on 96 well plates and transfected
using Lipofectamine 2000.
2.3. Receptor endocytosis and ligand binding studies in transiently
transfected HEK 293 cells
To determine the internalization kinetics of the AT1R, and AT2R
125I-AngII (2.5 kBq/ml, 0.03 nM) was added in 0.25 ml of
HEPES-buﬀered DMEM, and the cells were incubated at 37 C for
the indicated times. Incubations were stopped by placing the cells
on ice and rapidly washing them twice with ice-cold phosphate-buf-
fered saline. Acid-released and acid-resistant radioactivities were sep-
arated and measured by c-spectrometry as described previously [12].
The percentage of internalized ligand at each time point was calcu-
lated from the ratio of the acid-resistant speciﬁc binding to the total
(acid-resistant + acid-released) speciﬁc binding. The values for the
endocytotic rate constant (ke) (deﬁned as the probability of an occu-
pied receptor being internalized within 1 min at 37 C) were calcu-
lated based on the data obtained 2, 3 and 5 min after addition of
radiolabeled agonist, as described by Wiley and Cunningham [19].
The algorithms for this calculation were kindly provided by Dr.
H.S. Wiley (Salt Lake City, UT).
Cell surface angiotensin receptor binding was measured in cold dis-
placement studies using 125I-AngII or 125I-[Sar1,Ile8]AngII. The radioli-
gand (2.5 kBq/ml, 0.03 nM) and various concentrations of the
corresponding non-labeled ligand were added in 0.5 ml of HEPES-buf-
feredDMEM,and the cellswere incubatedat 4 Cfor 6 h ([Sar1, Ile8]An-
gII) or overnight (AngII). Following incubation, cells were washed twice
with ice-cold phosphate-buﬀered saline, and radioactivities were mea-
sured by c-spectrometry after solubilization with 0.5 M NaOH/0.05%
SDS. For data analyses nonlinear regression (curve ﬁt) with one site
competition was performed using GraphPad Prism 4.03 for Windows
(GraphPad Software, San Diego, CA, USA, www.graphpad.com).
2.4. BRET assay
Bioluminescence resonance energy transfer was measured between
b-arrestin2-Rluc and EYFP-tagged receptors [20]. For BRET assay
HEK 293 cells were grown on 96 well plates and transiently transfectedas described above. Forty-eight hours later coelenterazine h was added
in HEPES-buﬀered Hams F-12 to a ﬁnal concentration of 5 lM and
readings were collected immediately following this addition. Angioten-
sin II (100 nM) was added after the ﬁrst two measurements. The BRET
ratio is deﬁned as (emission at 530 nm)/(emission at 485), and the nor-
malized BRET ratio is calculated as the BRET ratio for the coexpres-
sed receptor-EYFP and b-arrestin2-Rluc constructs minus the BRET
ratio for the coexpressed non-tagged receptor and b-arrestin2-Rluc
constructs.
2.5. Confocal laser-scanning microscopy
For confocal microscopy, HEK 293 cells were grown on glass cover-
slips and transiently transfected as described above. Images were de-
tected with a Zeiss LSM 510 confocal laser-scanning microscope
48 h later. GFP and rhodamine were excited with argon (488 nm)
and helium/neon (543 nm) lasers, respectively, and emitted ﬂuores-
cences were detected in multitrack mode with 500–530 bandpass and
610 longpass ﬁlters, respectively.3. Results and discussion
3.1. Localization of b-arrestin2 during AngII stimulation in cells
expressing AT1R or AT2R
To detect the intracellular localization of the b-arrestin2
following AngII treatment of cells, we have coexpressed b-
arrestin2 fused with enhanced green ﬂuorescence protein (b-
arrestin2-EGFP) with AT1R or AT2R in HEK 293 cells. The
receptors were visualized by adding Rhod-AngII [21]. EGFP-
tagged b-arrestin2 has diﬀuse cytoplasmic localization in
unstimulated HEK 293 cells expressing either AT1R or
AT2R (Fig. 1A). Addition of 50 nM Rhod-AngII to the cells
transfected with AT1R caused its rapid endocytosis, and trans-
location of b-arrestin2-EGFP to the cell membrane and intra-
cellular vesicles (Fig. 1B) as described previously [5]. In
contrast, Rhod-AngII accumulated on the cell surface in
HEK 293 cells expressing AT2R, and no internalization of
the ﬂuorescent ligand was detected even 20 min after its addi-
tion (Fig. 1C). Moreover, no detectable b-arrestin2-EGFP
translocation to the membrane or intracellular structures was
observed after AngII treatment in AT2R-expressing cells
(Fig. 1C). These data suggest that, in contrast to AT1R and
most other GPCRs, agonist treatment does not induce associ-
ation of AT2R with b2-arrestin.
3.2. Internalization and binding properties of AT1R-EYFP and
AT2R-EYFP
For energy transfer studies AT1R and AT2R were labeled
with enhanced yellow ﬂuorescent protein (AT1R-EYFP and
AT2R-EYFP). The functional integrity of the AT1R-EYFP
was studied by comparing its internalization kinetics with
those of the wild-type receptors. In agreement with previous
ﬁndings [7], rapid internalization of 125I-labeled-AngII was de-
tected in cells expressing AT1R, and no diﬀerence was ob-
served between the internalization kinetics of the wild-type
AT1R and AT1R-EYFP (Fig. 2A). The endocytic rate con-
stants (ke) of AT1R and AT1R-EYFP were 0.52 ± 0.10 and
0.46 ± 0.08, respectively (n = 3). In contrast, no internalization
of labeled AngII was detected in cells expressing AT2R or
AT2R-EYFP (Fig. 2B), in agreement with previous data [12].
As their internalization was not detectable, AngII binding of
AT2R and AT2R-EYFP were compared in cold displacement
studies. The IC50 value of the EYFP-labeled receptor was com-
parable to that of the wild-type AT2R (0.87 ± 0.02 and
Fig. 1. Localization of EGFP-labeled b-arrestin2 (barr2GFP) during
stimulation of AT1R and AT2R. AT1R and AT2R were coexpressed
with barr2GFP in HEK 293 cells. Non-stimulated cells are shown in
panel A. The localization of barr2GFP (A, and middle panels of B and
C) and Rhod-AngII (top panels of B and C) is shown. The
superimposed image is shown in the lower parts of panels B and C.
Colocalized structures appear yellow.
Fig. 2. Internalization kinetics of angiotensin receptors. Internaliza-
tion kinetics of the receptors was determined by the measuring the
uptake of 125I-labeled AngII. Total speciﬁc 125I-AngII binding of
AT1R, AT2R, AT1R-EYFP and AT2R-EYFP at 30 min were
4136 ± 1248, 4441 ± 1069, 2459 ± 1197 and 2923 ± 446 cpm, respec-
tively (means ± S.E.M., n = 3). The percentage of internalized ligand at
each time point was calculated from the ratio of the internalized (acid-
resistant) speciﬁc binding to the total (acid-resistant + acid-released)
speciﬁc binding. Values are shown as means ± S.E.M. of three
independent experiments.
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aﬃnities of a peptide antagonist were determined in a parallel
set of experiments. Kd values of [Sar
1, Ile8]AngII binding to
AT1R, AT2R, AT1R-EYFP and AT2R-EYFP were 0.85 ±
0.09, 0.70 ± 0.05, 1.38 ± 0.03, and 1.03 ± 0.08, respectively
(means ± S.E.M., n = 3–4).
3.3. BRET analysis of coupling the b-arrestin2 to the AT1R and
AT2R
To further study the b-arrestin2 coupling to AT1R and
AT2R, b-arrestin2-Rluc was coexpressed in HEK 293 cells
with AT1R-EYFP or AT2R-EYFP and BRET was measured
following addition of coelenterazine h. After the second mea-
surement point AngII or medium was added to the cells and
measurements were taken in approximately every minute. As
shown on Fig. 3A marked elevation of normalized BRET ratio
was detected following stimulation with 100 nM AngII in cells
expressing AT1R-EYFP and b-arrestin2-Rluc. These data
show that, in agreement with previous data [22], agonist stim-
ulation induces direct interaction between the activated AT1R
and b-arrestin2. In contrast, no elevation of normalized BRET
ratio was observed upon addition of AngII (100 nM) in cells
expressing AT2R-EYFP and b-arrestin2-Rluc (Fig. 3B). These
data conﬁrm results with confocal microscopy and demon-
strate that AngII do not cause association of b-arrestin2 with
the activated AT2R.
A serine/threonine-rich region in the cytoplasmic tail of
AT1R, which includes Thr332, Ser335, Thr336 and Ser338, is
critically important for agonist-induced phosphorylation, inter-nalization and b-arrestin binding of the receptor [23]. Although
GRK-mediated phosphorylation of AT2R could not be de-
tected in a previous study [16], experiments with chimeric
AT1/AT2 receptors showed that internalization of AT1R, a b-
arrestin dependent process, is only partially impaired, if its cyto-
plasmic tail is substituted with that of AT2R [24]. These data
suggest that diﬀerences in the AngII-induced activation mecha-
nism and the sequences of the cytoplasmic tail are mutually
responsible for the major discrepancies in b-arrestin binding
and internalization kinetics of angiotensin receptors.
The inability ofAT2R tobindb-arrestin afterAngII treatment
is very unusual, since most activated GPCRs bind b-arrestins
after agonist treatment. Although internalization of some
GPCRs (e.g., N-formyl peptide receptor) is b-arrestin indepen-
dent, in most cases association with b-arrestins is readily detect-
able even for these receptors [25]. Earlier reports showed rare
examples of GPCRs that do not bind b-arrestins upon agonist
stimulation. For example, after prostaglandin E2 (PGE2) treat-
ment of cells expressing EP3 II, EP3 III or EP3 IV isoforms of
Fig. 3. BRET analysis of b-arrestin2 binding to AT1R and AT2R.
Normalized BRET ratios were determined in AngII-stimulated and
control cells coexpressing b-arrestin2-Rluc and AT1R-EYFP or AT2R-
EYFP. The initiation of AngII stimulation was marked with arrows.
Normalized BRET ratio is calculated as the BRET ratio (emission at
530 nm)/(emission at 485) for the coexpressed receptor-EYFP and b-
arrestin2-Rluc constructs minus the BRET ratio for the coexpressed
non-tagged receptor and b-arrestin2-Rluc. Values are shown as
means ± S.E.M. of at least three independent experiments.
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membrane was observed [26], and a recent report suggest that
the b3-adrenergic receptor has similar properties [27].
In conclusion, the present data demonstrate that agonist
stimulation of AT2Rs, in contrast to AT1Rs and most GPCRs,
is not followed by interaction of the activated receptor with
b-arrestins, which may explain the lack of agonist-induced
internalization. Furthermore, they also suggest that classical,
b-arrestin-mediated mechanisms do not participate in the
homologous desensitization of the AT2R, therefore its regula-
tion is diﬀerent from that of the AT1R and most other GPCRs.
Acknowledgments: This work was supported in part by a Collaborative
Research Initiative Grant from the Wellcome Trust (069416/Z/02/Z),
and by grants from the Hungarian Ministry of Public Health (ETT
036/2003) and the Hungarian Science Foundation (OTKA F-043073,
M-045341, T-046445 and Ts-049851).References
[1] Hunyady, L., Catt, K.J. (2006) Pleiotropic AT1 receptor signaling
pathways mediating physiological and pathogenic actions ofangiotensin II. Mol. Endocrinol., (in press) doi:10.1210/me.2004-
0536.
[2] De Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W. and
Unger, T. (2000) International union of pharmacology. XXIII.
The angiotensin II receptors. Pharmacol. Rev. 52, 415–472.
[3] Zhang, J., Ferguson, S.S.G., Barak, L.S., Menard, L. and Caron,
M.G. (1996) Dynamin and b-arrestin reveal distinct mechanisms
for G protein-coupled receptor internalization. J. Biol. Chem.
271, 18302–18305.
[4] Ga´borik, Z., Szasza´k, M., Szidonya, L., Balla, B., Paku, S., Catt,
K.J., Clark, A.J.L. and Hunyady, L. (2001) b-arrestin- and
dynamin-dependent endocytosis of the AT1 angiotensin receptor.
Mol. Pharmacol. 59, 239–247.
[5] Oakley, R.H., Laporte, S.A., Holt, J.A., Caron, M.G. and Barak,
L.S. (2000) Diﬀerential aﬃnities of visual arrestin, beta arrestin1,
and beta arrestin2 for G protein-coupled receptors delineate two
major classes of receptors. J. Biol. Chem. 275, 17201–17210.
[6] Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H.,
Pratt, R.E. and Dzau, V.J. (1993) Expression cloning of type 2
angiotensin II receptor reveals a unique class of seven-transmem-
brane receptors. J. Biol. Chem. 268, 24539–24542.
[7] Bottari, S.P., King, I.N., Reichlin, S., Dahlstroem, I., Lydon, N.
and De Gasparo, M. (1992) The angiotensin AT2 receptor
stimulates protein tyrosine phosphatase activity and mediates
inhibition of particulate guanylate cyclase. Biochem. Biophys.
Res. Commun. 183, 206–211.
[8] Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui,
H., Hamakubo, T. and Inagami, T. (1993) Molecular cloning of a
novel angiotensin II receptor isoform involved in phosphotyrosine
phosphatase inhibition. J. Biol. Chem. 268, 24543–24546.
[9] Yamada, T., Horiuchi, M. and Dzau, V.J. (1996) Angiotensin II
type 2 receptor mediates programmed cell death. Proc. Natl.
Acad. Sci. USA 93, 156–160.
[10] Huang, X.C., Richards, E.M. and Sumners, C. (1996) Mitogen-
activated protein kinases in rat brain neuronal cultures are
activated by angiotensin II type 1 receptors and inhibited by
angiotensin II type 2 receptors. J. Biol. Chem. 271, 15635–15641.
[11] Pucell, A.G., Hodges, J.C., Sen, I., Bumpus, F.M. and Husain, A.
(1991) Biochemical properties of the ovarian granulosa cell type 2-
angiotensin II receptor. Endocrinology 128, 1947–1959.
[12] Hunyady, L., Bor, M., Balla, T. and Catt, K.J. (1994) Identiﬁ-
cation of a cytoplasmic Ser-Thr-Leu motif that determines
agonist-induced internalization of the AT1 angiotensin receptor.
J. Biol. Chem. 269, 31378–31382.
[13] Ferguson, S.S.G. (2001) Evolving concepts in G protein-coupled
receptor endocytosis: the role in receptor desensitization and
signaling. Pharmacol. Rev. 53, 1–24.
[14] Wei, H., Ahn, S., Shenoy, S.K., Karnik, S.S., Hunyady, L.,
Luttrell, L.M. and Lefkowitz, R.J. (2003) Independent beta-
arrestin 2 and G protein-mediated pathways for angiotensin II
activation of extracellular signal-regulated kinases 1 and 2. Proc.
Natl. Acad. Sci. USA 100, 10782–10787.
[15] Spa¨t, A. and Hunyady, L. (2004) Control of aldosterone
secretion: a model for convergence in cellular signaling pathways.
Physiol. Rev. 84, 489–539.
[16] Olivares-Reyes, J.A., Jayadev, S., Hunyady, L., Catt, K.J. and
Smith, R.D. (2000) Homologous and heterologous phosphoryla-
tion of the AT2 angiotensin receptor by protein kinase C. Mol.
Pharmacol. 58, 1156–1161.
[17] Murphy, T.J., Alexander, R.W., Griendling, K.K., Runge, M.S.
and Bernstein, K.E. (1991) Isolation of a cDNA encoding the
vascular type-1 angiotensin II receptor. Nature 351, 233–236.
[18] Jayadev, S., Smith, R.D., Jagadeesh, G., Baukal, A.J., Hunyady,
L. and Catt, K.J. (1999) N-linked glycosylation is required for
optimal AT1a angiotensin receptor expression in COS-7 cells.
Endocrinology 140, 2010–2017.
[19] Wiley, H.S. and Cunningham, D.D. (1982) The endocytotic rate
constant. A cellular parameter for quantitating receptor-mediated
endocytosis. J. Biol. Chem. 257, 4222–4229.
[20] Eidne, K.A., Kroeger, K.M. and Hanyaloglu, A.C. (2002)
Applications of novel resonance energy transfer techniques to
study dynamic hormone receptor interactions in living cells.
Trends Endocrinol. Metab 13, 415–421.
[21] Hunyady, L., Baukal, A.J., Ga´borik, Z., Olivares-Reyes, J.A.,
Bor, M., Szasza´k, M., Lodge, R., Catt, K.J. and Balla, T. (2002)
G. Turu et al. / FEBS Letters 580 (2006) 41–45 45Diﬀerential PI 3-kinase dependence of early and late phases of
recycling of the internalized AT1 angiotensin receptor. J. Cell
Biol. 157, 1211–1222.
[22] Hansen, J.L., Theilade, J., Haunso, S. and Sheikh, S.P. (2004)
Oligomerization of wild type and nonfunctional mutant angio-
tensin II type I receptors inhibits galphaq protein signaling but
not ERK activation. J. Biol. Chem. 279, 24108–24115.
[23] Thomas, W.G. and Qian, H. (2003) Arresting angiotensin type 1
receptors. Trends Endocrinol. Metab 14, 130–136.
[24] Hunyady, L., Ga´borik, Z., Shah, B.H., Jagadeesh, G., Clark,
A.J.L. and Catt, K.J. (2004) Structural determineants of agonist-
induced signaling and regulation of angiotensin AT1 receptor.
Mol. Cell. Endocrinol. 217, 89–100.[25] Vines, C.M., Revankar, C.M., Maestas, D.C., LaRusch, L.L.,
Cimino, D.F., Kohout, T.A., Lefkowitz, R.J. and Prossnitz,
E.R. (2003) N-formyl peptide receptors internalize but do not
recycle in the absence of arrestins. J. Biol. Chem. 278, 41581–
41584.
[26] Bilson, H.A., Mitchell, D.L. and Ashby, B. (2004)
Human prostaglandin EP3 receptor isoforms show diﬀer-
ent agonist-induced internalization patterns. FEBS Lett.
572, 271–275.
[27] Breit, A., Lagace, M. and Bouvier, M. (2004) Hetero-oligomer-
ization between beta2- and beta3-adrenergic receptors generates a
beta-adrenergic signaling unit with distinct functional properties.
J. Biol. Chem. 279, 28756–28765.
